The Henry Ford production system: Measures of process defects and waste in surgical pathology as a basis for quality improvement initiatives

被引:40
作者
D'Angelo, Rita [1 ]
Zarbo, Richard J. [1 ]
机构
[1] Henry Ford Hlth Syst, Detroit, MI 48202 USA
关键词
quality improvement; lean; Henry Ford; Toyota; six sigma; measurement;
D O I
10.1309/X6N1Y3V2CB9HUL8G
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We implemented a continuous quality improvement initiative in pursuit of a "zero-defects " performance goal in surgical pathology that required design of novel data collection tools to assess our current condition and sources of defects and waste. We defined defect as a flaw, an imperfection, or a deficiency in specimen processing requiring delaying or stopping work or returning work to the sender These defects were noninterpretive, nondiagnostic defects critical to quality. Through a blameless work environment and contributions from all workers, we defined a baseline surgical pathology case defect rate of 27.9%, mostly arising in the laboratory (89.3%); only 8.3% were preanalytic; 2.4% resulted in amended reports. Additional focus on fidelity of patient and specimen identification allowed us to define defective identification in 1.67% of cases, with blocks and slides accounting for 78% of the defects. The misidentification defect rates per million opportunities for all sources were 4.3 to 4.8 sigma. These misidentification defects for 3 weeks required 159 hours of manual rework, or an annualized 1.3 full-time-equivalent employees. We found that through deep and honest exposure and the concerted effort of all workers, we could identify numerous sources of waste in our processes. This knowledge formed the structure for effective changes to strive toward a zero-defect performance goal.
引用
收藏
页码:423 / 429
页数:7
相关论文
共 14 条
[1]  
[Anonymous], AM J CLIN PATHOL S1
[2]  
[Anonymous], 1990, The Machine that Changed the World
[3]  
*COLL AM PATH COMM, 2006, TEAM LEAD ASS DIR QU
[4]   Error-free pathology: applying lean production methods to anatomic pathology [J].
Condel, JL ;
Sharbaugh, DT ;
Raab, SS .
CLINICS IN LABORATORY MEDICINE, 2004, 24 (04) :865-+
[5]  
DeMott K, 1997, Qual Lett Healthc Lead, V9, P18
[6]  
Ford Henry, 1926, TODAY TOMORROW
[7]  
*JOINT COMM ACCR H, 2007, LAB SERV NAT PAT SAF
[8]  
Liker JK., 2008, TOYOTA CULTURE HEART
[9]  
Nadzam D M, 1994, Healthc Inf Manage, V8, P13
[10]  
Ohno T., 1998, TOYOTA PRODUCTION SY